A Covid-19 inpatient registry is being considered nationwide to gather real-time insights that will help improve remedy outcomes, analyze trends in pandemic progression, and calibrate the response, authorities said.
CIMR, in collaboration with the Ministry of Health and AIIMS, plans to identify the national clinical record that will help researchers and policy makers perceive the effectiveness of experimental therapies, ongoing adverse situations and generate evidence to improve the remedy of Covid-19 patients.
“The purpose is to gather knowledge about patients hospitalized by COVID-19, such as clinical and laboratory characteristics, demographics, comorities, remedy results, headaches in all age groups, among others,” the authorities said.
Follow the coronavirus updates here
The new coronavirus, SARS-CoV-2 and the disease it causes have so many unknown parameters that clog and control the disease, they said.
“A comprehensive and systematic database covering other regions of the country will allow researchers and policymakers to generate applicable hypotheses, inform COVID 19 critics, uncover trends in pandemic progression, and calibrate pandemic reaction accordingly,” said one official.
Fifteen nationally recognized institutions, adding the Graduate Institute of Education and Medical Research (PGIMER) in Chandigarh, AIIMS Delhi, AIIMS Jodhpur, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru and Armed Force Medical College in Pune will join hospitals and physicians to integrate them.
Click for full coverage of the coronavirus
These 15 establishments would be the registration sites and would oversee about a hundred Covid-19 hospitals called satellite centres from which knowledge would be collected as a component of the exercise.
The proposal was sent for approval to the ICMR Central Committee for the Ethics of Human Research (CECHR). “Knowledge will help improve clinical control protocols because the repository would help us know which drug works most productively in which age group, the effectiveness of experimental treatments and the side effects that occur. The concept is to produce evidence to improve the COVID remedy -19 patients,” said some other official.
“O item.title”